NCT00571389View on ClinicalTrials.gov

A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.

RecruitingOBSERVATIONAL

Enrollment

1,500

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

February 28, 2030

Study Completion Date

February 28, 2030

Conditions

Solid Tumor, AdultHealthy DonorsCOVID-19 Donors

Trial Locations (1)

28078

RECRUITING

Carolina BioOncology Institute, Huntersville

Sponsors

Lead Sponsor

BioCytics, Inc.

All Listed Sponsors

lead

BioCytics, Inc.

INDUSTRY